Univ. Prof. Dr. Fahmy Aboulenein-Djamshidian

 Internationale Publikationen (Stand Jänner 2023)

  1. Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P.
    Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis. Ther Adv Chronic Dis. 2021; 28; 12: 20406223211024366. zum Artikel
  2. Hegen H, Walde J, Milosavljevic D, Aboulenein-Djamshidian F, Senel M, Tumani H, Deisenhammer F, Presslauer S. Free light chains in the cerebrospinal fluid.
    Comparison of different methods to determine intrathecal synthesis. Clin Chem Lab Med. 2019; 57: 1574-1586. zum Abstrakt
  3. Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.
    Month-of-birth-effect in multiple sclerosis in Austria. Mult Scler. 2018;  [ahead of Print] zum Artikel 
  4. Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P.
    Secondary dementia due to Lyme neuroborreliosis.
    Wien Klin Wochenschr. 2018; 15-16: 468-478. zum Artikel 
  5. Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M.
    Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.  
    J Neuroinflammation 2016 Jul 1; 13: 176. zum Artikel
  6. Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W.
    CROP – The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable? PLoS One 2015; 10: e0142272. zum Artikel
  7. Schanda K, Waters P, Holzer H, Aboulenein-Djamshidian F, Leite MI, Palace J, Vukusic S, Marignier R, Berger T, Reindl M.
    Antibodies to aquaporin-1 are not present in neuromyelitis optica.  Neurol Neuroimmunol Neuroinflamm 2015; 2: e160. zum Artikel
  8. Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M.
    NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases. 
    Neurol Neuroimmunol Neuroinflamm 2015; 2: e141. zum Artikel
  9. Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, Senel M, Tumani H, Hegen H.
    Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study. Mult Scler. 2015 Jul 21. zum Abstrakt
  10. Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W. 
    Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect? 
    J Neuropathol Exp Neurol 2015; 74: 194-197. 
    zum Artikel
  11. Assar H, Topakian R, Weis S, Rahimi J, Trenkler J, Höftberger R, Aboulenein-Djamshidian F, Ströbel T, Budka H, Yull H, Head MW, Ironside JW, Kovacs GG.
    A case of variably protease-sensitive prionopathy treated with doxycyclin.  
    J Neurology Neurosurg Psychiatry 2015; 86: 816-8. zum Abstrakt 
  12. Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher SC.
    Detection of retinal nerve fiber layer defects in Alzheimer‘s disease using SD-OCT. 
    Frontiers in Psychiatry 2014; 5:22. zum Artikel
  13. Serbecic N, Aboul-Enein F*, Beutelspacher SC, Khan A, Vass C, Kristoferitsch W, Reitner A, Schmidt-Erfurth U. 
    High-resolution spectral domain-optical coherence tomography in multiple sclerosis, Part II – the total macular volume. The first follow-up study over 2 years.
    Frontiers in Neurology 2014; 5:20. (*) equal contribution zum Artikel
  14. Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.
    Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people. PLoS One 2013; 8: e79649. zum Artikel
  15. Höftberger R, Sabater L, Marignier R, Aboul-Enein F, Bernard-Valnet R, Rauschka H, Ruiz A, Blanco Y, Graus F, 
    Dalmau J, Saiz A. 
    An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. 
    PLoS One 2013; 8: e79083. zum Artikel
  16. Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van’s Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A.
    Natalizumab therapy for highly active pediatric multiple sclerosis. JAMA Neurol 2013 70: 469-475. zum Artikel
  17. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M. 
    Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011 28; 8:184. zum Artikel
  18. Serbecic N, Aboul-Enein F*, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U. 
    High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years. PLoS One 2011; 6: e19843. 
    equal contribution(*) 
    zum Artikel
  19. Schmid S, Aboul-Enein F*, Pfisterer W, Birkner T, Stadek C, Knosp E.
    Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients. Neurosurgery. 2010; 67: 1703-1708. equal contribution(*) zum Abstrakt
  20. Serbecic N, Beutelspacher SC, Aboul-Enein F, Kircher K, Reitner A, Schmidt-Erfurth U. 
    Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography. 
    Br J Ophthalmol 2011;  95: 804-810. zum Abstrakt
  21. Serbecic N, Aboul-Enein F*, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U. 
    Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations. 
    PLoS One. 2010; 8: 5(11): e13877. (*) equal contribution
    zum Artikel
  22. Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H. 
    Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and betaendorphin. Endocrinology 2010; 151: 4801-4810. zum Abstrakt
  23. Höftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, Berki T, Ovadi J, Lassmann H, Budka H, Kovacs GG.
    Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia 2010; 58: 1847-1857. zum Abstrakt
  24. Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W.
    Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. 
    PLoS One 2010; 20: 5(7):e11625. zum Artikel
  25. Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M. 
    Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. 
    PLoS One. 2010; 5:e10455. zum Artikel
  26. Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W. 
    Diffuse white matter damage is absent in neuromyelitis optica. AJNR 2010; 31: 76-79. zum Artikel
  27. Serbecic N, Lahdou I, Scheuerle A, Höftberger R, Aboul-Enein F.
    Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.
    Mol Vis 2009; 15:1312-24. zum Artikel
  28. Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, Kristoferitsch W. 
    Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol. 2009; 19: 2535-2543. zum Abstrakt
  29. Aboul-Enein F, Kristoferitsch W. 
    Normal pressure hydrocephalus or neuroborreliosis? 
    Wien Med Wochenschr 2009; 159: 58-61. zum Abstrakt
  30. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W.
    Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. 
    Brain 2008; 131: 3072-3080. zum Artikel
  31. Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC.
    Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue. 
    J Neurooncol 2008; 87: 43-50. zum Abstrakt
  32. Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, Kristoferitsch W.
    Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome.
    Neuropathol Appl Neurobiol 2008; 34: 248-252. 
    zum Abstrakt

  33. Höftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtländer T, Oezen I, Amann G, Bernheimer H, Budka H, Berger J. 
    Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy.Neurobiol Dis 2007; 28: 165-174. zum Abstrakt 
  34. Rauschka H, Aboul-Enein F*, Bauer J, Nobis H, Lassmann H, Schmidbauer M.
    Acute cerebral white matter damage in lethal salicylate intoxication.
    Neurotoxicology. 2007; 28: 33-37. equal contribution (*) zum Abstrakt
  35. Pfisterer WK, Aboul-Enein F, Gebhart E, Graf M, Aichholzer M, Mühlbauer M. 
    Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus.
    Acta Neurochir 2007; 149: 983-990. zum Abstrakt
  36. Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J.
    Late-onset metachromatic leukodystrophy: Genotype strongly influences phenotype. 
    Neurology 2006; 67: 859-63. zum Abstrakt
  37. Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T.
    Advanced Intercross Line Mapping of Eae5 Reveals Ncf-1 and CLDN4 as Candidate Genes for Experimental Autoimmune Encephalomyelitis.
    J Immunol 2006; 176: 6055-64. zum Artikel
  38. Aboul-Enein F, Weiser P, Höftberger R, Lassmann H, Bradl M.
    Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis.
    Acta Neuropathol 2006; 111: 539-47. zum Abstrakt
  39. Aboul-Enein F, Lassmann H. 
    Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? 
    Acta Neuropathol 2005;109: 49-55. zum Abstrakt
  40. Aboul-Enein F, Bauer J, Klein M, Schubart A, Flügel A, Ritter T, Kawakami N, Siedler F, Linington C, Wekerle H, Lassmann H, Bradl M. 
    Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation. J Neuropathol Exp Neurol 2004; 63: 1284-96. zum Abstrakt
  41. Loers G,  Aboul-Enein F*, Bartsch U, Lassmann H, Schachner M. Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study.
    Mol Cell Neurosci 2004; 27: 175-89. equal contribution (*) zum Abstrakt
  42. Höftberger R, Aboul-Enein F*, Brück W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H.
    Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.Brain Pathol 2004; 14: 43-50. equal contribution (*) zum Abstrakt
  43. Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, Pena-Rossi C.
    CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    J Neuroimmunol 2003; 145: 1-11. 
    zum Abstrakt
  44. Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, Olsson T, Lorentzen JC. 
    Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats. 
    Eur J Immunol 2003; 33: 1907-16. zum Abstrakt
  45. Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Bruck W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M.
    A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.
    Brain 2003; 126: 1347-57. zum Artikel
  46. Aboul-Enein F*, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H.
    Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.
    J Neuropathol Exp Neurol 2003; 62: 25-33. equal contribution (*) zum Abstrakt

    Comments, letters to the editor etc.

    • Aboul-Enein F, Kristoferitsch W. 
      Discrepancy of data? (comment to J Neurol Neurosurg Psychiatry 2010;81:409-411 doi:10.1136/jnnp.2008.168070)JNNP. recent e-Letters; published 23 June 2010. 
    • Aboul-Enein F. 
      Comment on the article entitled ‘Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis’ by Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, Malikova I, Soulier E, Viout P, Ranjeva JP, Pelletier J, Audoin B. (comment to J Neurol Neurosurg Psychiatry 2010; doi:10.1136/jnnp.2010.213744) JNNP. recent e-Letters; published 12 January 2011.
    • Aboul-Enein F. 
      Comment on „Global N-Acetylaspartate Declines Even in Benign Multiple Sclerosis“ AJNR Am J Neuroradiol. 2011 Apr 28. zum Brief 
    • Aboulenein-Djamshidian F, Serbecic N, Kristoferitsch W. Optical coherence tomography in multiple sclerosis. Lancet Neurol. 2016 May;15(6):537-8. zum Letter 
    • Aboulenein-Djamshidian F, Serbecic N. OCT is an alternative to MRI for monitoring MS – NO. Mult Scler. 2018 doi: 10.1177/1352458518754366. 
      zum Kommentar